Eating Disorder Screening Tests: Uses and Limits
Author: Angela Bogdanova · Published: October 10, 2026 · Editorial Policy
Research cluster: Eating Disorders & Disordered Eating · Written by Artificial Sapiens
Eating disorder screening tests can help identify people whose eating behaviors, food-related fears, or concerns about eating and body shape deserve further clinical attention. They are brief ways of recognizing possible problems, not diagnostic examinations. A positive result means that a professional assessment may be appropriate; a negative result cannot safely exclude an eating disorder when a person's history, symptoms, growth pattern, or physical condition raise concern. The NICE eating-disorder guideline explicitly warns against relying on tools such as SCOFF as the sole method of identifying an eating disorder.
The central question is what a questionnaire can actually tell you. Different tools examine different behaviors, populations, and diagnoses. Some were developed to detect classical anorexia- or bulimia-related symptoms, some quantify eating-disorder psychopathology, and others address binge eating or avoidant/restrictive food intake disorder (ARFID). Choosing a questionnaire, interpreting its responses, and deciding what to do afterward require attention to context, validity, medical risk, and the person's reason for seeking help. For a complete account of the next clinical steps, see How Are Eating Disorders Diagnosed? Assessment and Criteria.
What is an eating disorder screening test?
An eating disorder screening test is a set of standardized questions intended to flag possible eating-disorder symptoms or elevated risk and identify whether fuller evaluation is warranted. Screening generally involves limited information collected quickly, often in a primary care visit, school or college health setting, specialist intake, or online questionnaire. It may ask about restrictive eating, eating-related distress, perceived loss of control, compensatory behaviors, preoccupation with weight or shape, or particular food-avoidance experiences.
A screening test answers a probabilistic question: might a clinically meaningful problem be present? A diagnostic assessment answers a broader clinical question: which condition, if any, best explains the person's behavior, beliefs, medical history, functioning, and physical findings? A symptom is an experience or behavior; a risk factor increases the likelihood of a condition; a screening result reflects responses measured by one instrument; a diagnosis is a professional conclusion based on established criteria and the overall assessment. The American Psychiatric Association's eating disorders practice guideline and NICE recommendations place screening within a larger clinical process.
A standardized questionnaire may help a person name experiences they have struggled to describe. It may also help a clinician ask questions consistently or monitor particular symptoms over time. These advantages depend on the instrument fitting the patient and setting. A person with a medically significant eating disorder may not recognize its symptoms, may interpret questions differently, or may have a presentation the selected questionnaire does not assess.
Screening, case-finding, diagnosis, and monitoring
The term screening is often used loosely, but several activities have distinct purposes. Universal or population screening systematically offers a test to people without identified symptoms. Case-finding involves further questions when a clinician notices indicators such as food restriction, changing growth patterns, unexplained physical findings, recurrent binge eating, or a family member's concern. Diagnostic assessment investigates a suspected condition. Symptom monitoring follows change during treatment or recovery.
The distinction matters because evidence about a tool's ability to classify cases cannot, by itself, prove that testing every asymptomatic person improves health. In its 2022 recommendation, the US Preventive Services Task Force (USPSTF) concluded that evidence was insufficient to assess the balance of benefits and harms of routine eating-disorder screening among asymptomatic adolescents and adults aged 10 years or older. This is an I statement about population screening, not advice to ignore suspected illness or refuse clinical assessment.
Clinical organizations emphasize active recognition and timely evaluation when symptoms or concerns arise. The American Academy of Pediatrics clinical report describes the pediatrician's role in identifying concerning eating behaviors and monitoring development; NICE calls for assessment and prompt referral when an eating disorder is suspected. Those positions address clinical attention and case-finding rather than establishing that one universal questionnaire has proven population-level benefit.
What can a screening questionnaire detect?
Most established questionnaires sample clusters of thoughts and behaviors associated with particular eating-disorder presentations. They may flag severe food rules, fear related to eating or weight gain, distress about shape or weight, recurrent loss-of-control eating, attempts to compensate for eating, or persistent restriction. Other measures focus on low interest in food, sensory features, or fear of adverse consequences of eating, which can be important for ARFID.
They generally cannot determine an exact DSM-5-TR or ICD-11 diagnosis without further information. For example, an elevated general eating-attitudes score does not distinguish anorexia nervosa, atypical anorexia nervosa, bulimia nervosa, binge eating disorder, and other specified feeding or eating disorder (OSFED). Nor does it establish how medically unwell someone may be. The National Institute of Mental Health overview outlines the different behavioral patterns and health consequences of anorexia, bulimia, binge eating disorder, and ARFID.
The patient's experience may also span categories: restrictive eating and binge episodes can coexist over time; eating-related anxiety can arise from gastrointestinal illness or fear of choking; compulsive food rituals can overlap with obsessive-compulsive disorder; and preoccupation with appearance can occur in several conditions. The purpose and consequences of a behavior matter as much as its presence on a checklist. Screening is therefore an entry point into a careful conversation.
The most common eating disorder screening tests
SCOFF: a short case-identification questionnaire
SCOFF consists of five brief questions originally designed to flag possible anorexia- and bulimia-spectrum problems. Its name reflects the original questions' themes; the instrument has been widely examined in primary care and other settings. The original development paper was published by Morgan, Reid, and Lacey in the BMJ. Its usual scoring rule identifies a response pattern warranting further evaluation, but this threshold does not turn the result into a diagnosis or establish an individual's medical stability.
The strongest pooled accuracy evidence is for adult populations, especially women, and performance depends on setting and reference standard. In the evidence review supporting the USPSTF recommendation, SCOFF's commonly studied threshold had pooled sensitivity of approximately 84% and specificity of approximately 80% in adults across ten studies. These are group-level estimates with substantial uncertainty and variation; they are not a promise that every person with an eating disorder will test positive.
A five-question instrument inevitably has coverage gaps. It can fail to characterize binge eating disorder, ARFID, atypical anorexia, purging presentations, or complex patterns that do not match its original assumptions. People of different genders, cultures, ages, and eating-disorder presentations may interpret items differently. A clinician may still need to pursue an assessment after a low SCOFF result when the history is concerning.
EAT-26: eating attitudes and associated symptoms
The Eating Attitudes Test, commonly called EAT-26 in its shortened form, assesses attitudes and behaviors associated with disordered eating, including food-related concerns and restraint. It has been used in research, educational settings, and clinical contexts. Its original development and psychometric work was reported by Garner and colleagues. A score is an indicator for follow-up according to the instrument's intended use, not a diagnostic verdict.
The measure's historical development sample and symptom emphasis are important limitations. It was not designed to identify every modern diagnostic presentation equally well. A 2022 psychometric study identified measurement concerns in a mixed adult sample, including differences in item functioning by weight category and limitations at lower levels of measured risk. Findings from one sample should not be generalized indiscriminately, but they illustrate why an established questionnaire must still be evaluated for its intended population.
Online versions may combine the EAT-26 items with additional behavioral questions and different interpretations. A displayed score can look precise while concealing differences in version, translation, sampling, and thresholds. Before interpreting a result, a professional should know which version was administered, whether it was validated for the person and setting, and what clinical action the result is supposed to inform.
EDE-Q: a detailed eating-disorder symptom measure
The Eating Disorder Examination Questionnaire (EDE-Q) is a longer self-report measure of eating-disorder psychopathology, designed in relation to the clinician-administered Eating Disorder Examination interview. It examines domains such as eating concerns and shape- or weight-related concerns, along with reported behaviors. The foundational comparison by Fairburn and Beglin found meaningful differences between self-report and interview-based assessment for some complex features, demonstrating why the two methods cannot be regarded as interchangeable.
EDE-Q can be useful in research, specialist assessment, and monitoring, but its scores require knowledge of the version, normative data, clinical context, and interpretation procedures. It should not be treated as a stand-alone diagnostic test. The NICE guideline refers to standardized outcome measures, including EDE-Q, as part of evaluating treatment progress. An outcome measure can help track change without substituting for ongoing physical and psychiatric evaluation.
Because EDE-Q concentrates heavily on traditional eating-disorder symptom dimensions, its ability to characterize ARFID and some other presentations is limited. If an individual restricts food because of sensory distress or fear of choking rather than weight or shape concerns, a specialist needs questions tailored to those mechanisms as well as an appropriate medical differential assessment.
A new systematic review and meta-analysis published in 2026 pooled 18 EDE-Q accuracy studies. The full questionnaire had estimated sensitivity of 84% and specificity of 86%, while shorter forms pooled 75% and 82%, respectively. Results differed across diagnoses and participant groups, with higher accuracy for bulimia nervosa and variation by age and gender. These findings strengthen the evidence for EDE-Q as a screening measure in studied settings while leaving important limits on individual diagnosis, representation of ARFID, and transportability of a single cutoff. See Park and Kim's 2026 systematic review.
BEDS-7: focused screening for binge eating disorder
The seven-item Binge Eating Disorder Screener (BEDS-7) was developed to identify probable binge eating disorder for further evaluation. Its questions draw on the disorder's clinical features, particularly recurrent eating episodes associated with loss of control and distress. The original development study evaluated a small clinical sample and reported high sensitivity but low specificity for the selected algorithm, which means many people who screened positive would require follow-up to determine whether they met full diagnostic criteria.
The initial study had a limited sample size, and the authors reported industry affiliations; replication and population-specific validation matter when judging generalizability. BEDS-7 is not an all-purpose eating-disorder screen. A result relevant to binge eating cannot rule out restrictive eating, bulimia, ARFID, or nutritional compromise. Distress and loss of control also require assessment of context, frequency, associated features, and competing explanations.
The distinction between ordinary overeating, an episode of loss-of-control eating, and binge eating disorder rests on the larger clinical pattern and impairment. Someone need not fit a particular body size to experience binge eating disorder, and a body measurement does not confirm the condition.
NIAS: identifying possible ARFID features
The Nine Item ARFID Screen (NIAS) examines three symptom domains associated with avoidant/restrictive food intake disorder: sensory-based selectivity, low appetite or limited interest in eating, and fear of adverse consequences of eating. A 2021 validation study examined its subscales among people with diagnosed ARFID, other eating disorders, and nonclinical participants. It proposed approaches for identifying ARFID-related symptoms while showing that differentiation from other eating disorders required additional assessment.
ARFID is a recognized feeding or eating disorder whose restrictive intake is not driven primarily by the weight- or shape-related concerns characteristic of anorexia nervosa. Screening therefore needs to consider impairment, nutritional adequacy, growth, and the possibility of other medical or mental health explanations. The NIAS has clinical research support, but performance varies with age, sample, and combined measures. Its subscale patterns describe symptoms; they cannot independently establish ARFID or exclude a gastrointestinal, swallowing, sensory, or anxiety-related condition.
A child who eats a narrow range of foods is not automatically experiencing ARFID. Assessment considers developmental history, nutrition and growth, distress, social functioning, and whether the difficulties exceed what would be expected from ordinary selectivity or another condition. Parents and caregivers often contribute essential observations to this evaluation.
Which test should you use?
There is no universally best questionnaire for every eating-disorder question. A primary care clinician looking for broad potential anorexia- or bulimia-spectrum problems may consider brief case-identification questions. A specialist following the course of treatment may use a more detailed symptom scale. A clinician investigating recurrent binge episodes needs disorder-specific questions, while ARFID-related food avoidance calls for tools addressing appetite, sensory experience, or fear of consequences.
Instrument selection should follow the assessment goal, the patient's age and developmental level, the setting, the suspected presentation, the language of administration, and the availability of validated interpretation data. A tool appropriate in a research study of adult women may perform differently with younger adolescents, men, gender-diverse patients, people from different cultural backgrounds, or adults with chronic medical conditions. The USPSTF evidence review found limited accuracy evidence for many specific populations.
It may be reasonable to use structured questions as part of a professional encounter, while recognizing that no one score controls the care pathway. Someone seeking support because food has become frightening or unmanageable deserves a clinical conversation even if a web quiz recommends no further action.
How accurate are eating disorder screening tests?
Accuracy is not a single permanent property of a questionnaire. Sensitivity describes the proportion of people with the condition who receive a positive test result in a studied sample. Specificity describes the proportion of people without that condition who receive a negative result. False negatives are missed cases; false positives are results that trigger further evaluation even though the target diagnosis is ultimately not present.
The practical meaning of a positive result also depends on how common the condition is in the population being tested. A questionnaire with seemingly good sensitivity and specificity can produce many false positives when applied across a low-prevalence population. A positive screening score is therefore a signal to investigate, rather than a clinical label. Conversely, imperfect sensitivity means a negative result can miss someone whose clinical history clearly warrants attention.
Accuracy studies can overestimate real-world performance when they compare conspicuous specialist cases with healthy controls. Other sources of variation include translated items, the choice of diagnostic interview used as the reference, whether participants already know they have an eating disorder, the instrument's threshold, and the time frame of symptoms. Comparisons across published studies require care because they may not be testing the same clinical question.
The USPSTF systematic evidence summary considered accuracy evidence along with the separate question of whether screening followed by treatment improves outcomes. No directly eligible study established the overall health benefit or harm of universal screening in asymptomatic people. Evidence that a questionnaire recognizes some cases is therefore different from evidence that population-wide use improves health.
What does a positive screening result mean?
A positive result means that the person's reported answers crossed a tool-specific threshold or matched a response pattern associated with possible eating-disorder symptoms. It provides a reason to ask more questions and consider a professional assessment. It does not establish anorexia, bulimia, binge eating disorder, ARFID, OSFED, or another diagnosis; it also does not determine whether inpatient care is needed.
Follow-up should explore what the person actually experiences: whether eating has become restricted, frightening, compulsive, or associated with shame; whether there is perceived loss of control; whether compensatory behaviors occur; whether physical symptoms have developed; and how eating affects school, work, relationships, and everyday functioning. When medical risk is suspected, evaluation may include vital signs, growth and weight trajectories, a physical examination, relevant laboratory tests, and cardiac testing when clinically indicated. NICE and the APA practice guideline describe the importance of assessing physical and psychiatric health alongside symptoms.
When the screening was completed privately online, the individual can bring the questions or result to a primary care professional or eating-disorder specialist. Explaining concrete concerns is more useful than insisting that a numerical result proves a particular diagnosis. It is also appropriate to seek evaluation without completing any questionnaire first.
What does a negative result mean?
A negative result means the questionnaire did not flag the selected symptoms at the chosen threshold on that occasion. It does not certify that eating is safe, that nutrition is adequate, or that a particular diagnosis is absent. Tests may miss people who minimize symptoms, misunderstand questions, have changing symptoms, or present with a disorder the scale is poorly designed to detect.
A negative SCOFF, for example, cannot reliably exclude ARFID, a binge-eating presentation, or a medically dangerous restrictive pattern outside classical assumptions. Someone may have substantial nutritional compromise at a higher body weight, or may have rapid change relative to their own developmental trajectory while their current measurements appear ordinary. NICE specifically advises against using BMI or duration of illness as a single basis for deciding whether treatment is needed.
If the person, family, caregiver, or clinician remains concerned, further evaluation is justified regardless of the score. Screening is meant to support recognition, not to create an obstacle to receiving care.
Why online eating disorder quizzes have important limits
Online questionnaires can improve awareness and provide an accessible starting point for people who are uncertain about their experiences. They can also be misleading when the site fails to identify the tool, applies an unvalidated score interpretation, presents a diagnostic label, or omits instructions about urgent medical warning signs. A familiar instrument name does not ensure that the specific web implementation preserves the validated wording or scoring.
The context of responding matters. Someone may disclose more in a private setting than during a medical appointment, but internet anonymity can make it harder to interpret responses or arrange meaningful follow-up. Some websites also collect sensitive health-related information. Before submitting answers, consider whether the publisher identifies the measure, explains how results are interpreted, describes its privacy practices, and offers a clinically sensible next step.
No online result can examine pulse, blood pressure, hydration, electrolytes, growth trajectories, or the wider mental health picture. The absence of a dramatic-looking result has no power to rule out urgent medical needs. Information about online screening should support professional assessment rather than replace it.
Can a screening test diagnose anorexia, bulimia, binge eating disorder, or ARFID?
Diagnosis depends on the person's symptom history, diagnostic criteria, functional consequences, and clinical judgment. Anorexia nervosa involves a particular pattern of restrictive intake and weight-related psychopathology; atypical anorexia is an OSFED presentation in which the relevant clinical picture can exist without low body weight. Bulimia nervosa includes recurrent binge eating and compensatory behaviors; binge eating disorder involves recurrent binge episodes with associated distress and without the recurrent inappropriate compensatory behavior that defines bulimia. ARFID involves clinically significant avoidance or restriction linked to nutritional or functional consequences, without the central weight/shape-driven motivation of anorexia.
OSFED and unspecified feeding or eating disorder (UFED) recognize clinically significant presentations that do not fit another diagnosis's complete criteria or where information is insufficient. Pica and rumination disorder have their own diagnostic frameworks and may be missed by instruments focused on thinness and body concerns. Orthorexia is a popular and researched concept for a rigid preoccupation with perceived healthy eating, but it is not a separately established DSM-5-TR diagnosis. A general screen cannot sort all of these distinctions without specialist evaluation. The NIMH clinical overview provides accessible information about major recognized conditions.
Overlapping symptoms can require additional differential assessment. For example, repeated food avoidance may stem from swallowing problems, a specific fear of choking, ARFID, a gastrointestinal disorder, obsessive-compulsive symptoms, or several causes together. Detailed history helps determine which explanation best accounts for the person's experience and which medical evaluations are necessary. For clinically relevant distinctions, compare OCD vs Eating Disorders.
Screening across ages, genders, and body sizes
Children and adolescents
Children may communicate distress through changed meals, food refusal, fatigue, social withdrawal, or difficulty eating with peers rather than through the language used in adult questionnaires. Clinicians also consider growth curves, expected developmental progression, pubertal changes, school functioning, and family observations. The AAP clinical report and Society for Adolescent Health and Medicine position paper emphasize developmental and medical assessment of young people with suspected eating disorders.
Age-appropriate conversations and confidential time with adolescents can be important, while caregivers may provide information about behaviors, changes, and safety concerns that a self-report measure misses. The evidence base for adult screening questionnaires does not transfer automatically to children. Clinical judgment and developmentally appropriate follow-up remain central.
Men, gender-diverse people, and underrepresented communities
Many well-known questionnaires were developed or validated disproportionately in samples of women and in settings where thinness-focused symptoms were prominent. Men and gender-diverse people may describe a different mix of concerns, including muscularity, compulsive exercise, body-related distress, restrictive eating, or binge eating. Individuals may also experience stigma that makes disclosure difficult. Interpretation should be tailored to the person rather than to assumptions about who develops eating disorders.
Culture and language influence how questions are understood, and different food practices need context-sensitive inquiry. A questionnaire validated in one language or clinical population should not be assumed equally accurate after translation or use in another group. The USPSTF evidence review identifies important gaps in population-specific accuracy data.
People across the weight spectrum
An eating disorder can occur at many body sizes. A single BMI measurement cannot show how quickly nutrition has changed, what compensatory behaviors are occurring, or whether cardiovascular and metabolic instability is developing. Weight history, rate of change, restriction, hydration, vital signs, growth, and symptoms may be more informative than appearance alone. The Society for Adolescent Health and Medicine explicitly addresses restrictive eating disorders including atypical anorexia and ARFID.
Weight-based assumptions may also delay recognition of binge eating disorder or bulimia. People deserve evaluation according to their behaviors, distress, impairment, and health risks, not an externally presumed body category.
What a professional assessment involves after screening
A qualified clinician starts by asking about the person's concerns and symptom course. The history may cover food avoidance, restriction, binge episodes, compensatory behavior, exercise, body image where relevant, sensory or gastrointestinal experiences, weight and growth history, medications, illnesses, past treatment, sleep, mood, anxiety, and potential trauma. Questions about suicidality or self-harm may be relevant when indicated by the wider clinical assessment.
The medical component is individualized. It may include measuring vital signs, assessing hydration and nutritional status, reviewing growth or weight changes, testing for relevant electrolyte or other abnormalities, and obtaining an electrocardiogram when symptoms or risk factors indicate. Normal results in one laboratory panel do not conclusively exclude an eating disorder. In young people, clinicians also look for faltering growth or delayed puberty. NICE describes physical and psychological assessment, while the APA guideline addresses diagnostic evaluation and treatment planning.
A clinician considers differential diagnoses such as gastrointestinal disease, endocrine conditions, swallowing disorders, medication effects, food allergies where relevant, neurodevelopmental differences, obsessive-compulsive symptoms, depression, and anxiety. An initial impression may change as more information becomes available. Referral to an eating-disorder service, pediatric or adolescent medicine, psychiatry, psychology, or an experienced registered dietitian depends on the clinical picture and local care system.
Screening results can be kept as one piece of the record and revisited if useful. They do not determine treatment modality by themselves. An eating-disorder diagnosis, its severity, medical stability, developmental stage, and patient preferences all influence what care is appropriate.
When to seek help even without a positive test
Professional assessment is appropriate when eating patterns create persistent distress or impairment; someone fears food or eating; recurrent loss-of-control episodes occur; restrictive eating or compensatory behavior is present; the range of tolerated foods is narrowing with nutritional consequences; or family members notice concerning changes. Unexplained changes in growth, energy, menstruation, gastrointestinal symptoms, dizziness, or food-related social withdrawal also merit attention.
Some symptoms call for urgent medical evaluation regardless of screening status. Fainting, chest pain, significant palpitations, severe weakness or confusion, signs of marked dehydration, persistent vomiting, or concern about dangerous electrolyte disturbance require prompt medical assessment. If the person is medically unstable or at imminent risk of self-harm, seek emergency services. The NICE recommendations identify compromised physical health and acute suicide risk as reasons for emergency assessment. More detail on triage and urgent warning signs appears in When Is an Eating Disorder a Medical Emergency? Warning Signs.
A person does not need to wait for the situation to become severe before contacting primary care or a specialist. Early recognition can reduce delays in obtaining an assessment, especially when the person feels unsure whether their difficulties are serious enough.
What are the potential benefits and harms of screening?
Appropriately chosen screening questions may bring hidden symptoms into a conversation, prompt timely referral, and create a consistent way of checking concerns in a clinical encounter. Some individuals feel more able to describe a problem after seeing questions that name behaviors they had not previously discussed. For clinicians, screening can create opportunities to ask about eating that might otherwise be overlooked.
Potential problems include false reassurance from a negative result, needless alarm or mislabeling after a false positive, stigma, privacy concerns, and delays if a clinic requires a threshold before listening to patients. A highly focused questionnaire can also anchor attention on one diagnosis while missing another. The USPSTF recommendation found insufficient direct evidence to determine whether universal screening of asymptomatic people improves outcomes, even though several instruments have demonstrable test accuracy in some populations.
A sound screening pathway therefore specifies what happens after a positive result, how concerning symptoms are addressed despite a negative result, who provides assessment, and how urgent medical needs are recognized. The greatest practical value comes from integrating questionnaires into responsive care.
What about treatment and recovery after screening?
A screening result is the beginning of assessment, not a treatment plan. When an eating disorder is diagnosed, evidence-based care is selected for the specific condition, age group, medical risk, and circumstances. Treatment commonly combines psychological care, nutritional rehabilitation or support, and medical monitoring as indicated. For adolescents with some restrictive eating disorders, family involvement may be especially important; for adults with bulimia or binge eating disorder, structured psychological treatments may be recommended. Detailed choices belong to diagnosis-specific guidelines and clinical discussion.
The NICE guideline distinguishes care for anorexia, bulimia, binge eating disorder, and other presentations, and the APA practice guideline sets out evidence-based evaluation and treatment approaches. Neither suggests selecting a therapy based solely on a screening score.
During recovery, questionnaires may help describe shifts in reported symptoms, but clinicians also review functioning, eating patterns, medical status, goals, and lived experience. Improved scores are useful information; they do not establish medical recovery by themselves. Changes in a symptom scale and changes in actual safety or daily functioning are related but distinct outcomes.
How to use screening results responsibly
A practical approach begins with describing the concern rather than searching for the perfect score. If an online or clinical questionnaire raised concern, save the name of the instrument and the date, and arrange an appointment with a qualified professional. Describe the experiences that led you to take the test, including changes in eating, distress, feared consequences, or symptoms affecting daily life. The clinician may use the questionnaire as a prompt and decide which further questions or examinations are appropriate.
If the score seems reassuring while important symptoms continue, prioritize those symptoms. If a score is alarming but its meaning is unclear, seek interpretation without treating the result as a diagnosis. Parents and caregivers can convey changes they have seen while maintaining a respectful, collaborative conversation with the young person. People supporting a loved one should focus on wellbeing, observable concerns, and access to assessment.
For clinics or educational organizations, responsible implementation includes choosing an instrument validated for the intended population, training staff, protecting privacy, setting a clear referral route, and evaluating whether the process actually helps people receive appropriate care. A questionnaire without an appropriate follow-up pathway offers limited benefit.
Frequently asked questions
Can an online test tell me whether I have an eating disorder?
An online questionnaire can indicate possible symptoms, but it cannot determine a diagnosis. If concerns persist, a clinician needs to review the history, functioning, diagnostic criteria, and physical health. A negative result does not override meaningful symptoms.
What is the difference between SCOFF and EAT-26?
SCOFF is a very short case-identification questionnaire originally built around typical anorexia- and bulimia-related concerns. EAT-26 samples a broader set of eating attitudes and behaviors. Their scores, development populations, and validation evidence differ, so they are not interchangeable and neither independently diagnoses an eating disorder.
Is SCOFF accurate enough to diagnose an eating disorder?
No. Its sensitivity and specificity have been studied, particularly in adults, but it can produce both missed cases and false alarms. The NICE guideline instructs clinicians not to use SCOFF or another screening tool as the sole way to determine whether someone has an eating disorder.
Can I have an eating disorder with a low EAT-26 score?
Yes. Scores depend on what the questionnaire asks and how the person answers. Some disorders or symptom patterns are not captured well by traditional eating-attitudes questions, and medical risk is assessed separately.
Is EDE-Q a screening test or a diagnostic test?
EDE-Q is a self-report measure of eating-disorder psychopathology used in assessment and research and sometimes in tracking treatment outcomes. It is not equivalent to a clinician-administered diagnostic interview. Its interpretation depends on the population and clinical context.
Is there a screening test for binge eating disorder?
BEDS-7 is one tool designed to flag probable binge eating disorder for follow-up. Its initial validation has limitations, and a positive result requires assessment of episode patterns, distress, associated features, and other explanations. It cannot screen for all feeding or eating disorders.
Is there a screening test for ARFID?
NIAS measures symptom domains related to ARFID, including sensory selectivity, limited appetite or interest, and fear of consequences of eating. A positive result warrants context-sensitive assessment of nutrition, functioning, and other potential medical or psychological explanations.
Can eating disorders occur at a normal or higher BMI?
Yes. Body size alone neither establishes nor excludes an eating disorder or its medical risks. Clinicians evaluate behaviors, symptoms, rate of change, nutritional state, vital signs, and developmental history.
Does the USPSTF recommend that nobody be screened?
No. The 2022 USPSTF I statement concerns universal screening of people without signs or symptoms because the net benefit remains uncertain. It does not discourage clinicians from investigating symptoms, considering risk factors, or evaluating patients with suspected illness.
Should adolescents take the same eating disorder questionnaires as adults?
Not automatically. Developmental stage, growth, communication, and validation samples matter. Pediatric care often combines age-appropriate questions with clinical history, growth review, physical assessment, and family observations when appropriate.
Can a screening questionnaire detect orthorexia?
Some questionnaires explore rigid healthy-eating preoccupations, but orthorexia has no separate established DSM-5-TR diagnostic category. An instrument using that label requires careful interpretation. Clinicians evaluate distress, impairment, nutritional concerns, and overlap with recognized disorders rather than treating an internet score as a formal diagnosis.
What should I do if a test is positive but I feel physically okay?
Arrange a professional assessment, because physical complications can develop without being obvious from appearance or subjective wellbeing. Seek urgent care when serious physical symptoms occur. The screening score is information to bring to the appointment, not evidence that the condition is harmless or severe.
Can questionnaires track eating disorder recovery?
They can help describe changes in specific reported symptoms when selected and interpreted appropriately. Recovery is assessed more broadly through eating patterns, medical stability, psychological wellbeing, functional life, and individualized clinical goals.
Related Articles
How Are Eating Disorders Diagnosed? Assessment and Criteria explains what follows a preliminary screening result, including diagnostic interviews and medical evaluation.
When Is an Eating Disorder a Medical Emergency? Warning Signs addresses urgent concerns that require evaluation regardless of questionnaire score.
OCD vs Eating Disorders: What Is the Difference? examines overlapping rituals, food-related fears, and diagnostic reasoning.
Choking Phobia: Fear of Choking, Eating Avoidance, and Differential Diagnosis provides context for one possible explanation of eating avoidance that requires specialized assessment.
References
American Academy of Pediatrics. Hornberger, L. L., & Lane, M. A. (2021). Identification and management of eating disorders in children and adolescents. Pediatrics, 147(1), e2020040279. https://doi.org/10.1542/peds.2020-040279
American Psychiatric Association. (2023). The American Psychiatric Association practice guideline for the treatment of patients with eating disorders, fourth edition. APA clinical practice guidelines.
Burton Murray, H., Dreier, M. J., Zickgraf, H. F., et al. (2021). Validation of the nine item ARFID screen (NIAS) subscales for distinguishing ARFID presentations and screening for ARFID. International Journal of Eating Disorders, 54, 1782–1792. https://doi.org/10.1002/eat.23520
Fairburn, C. G., & Beglin, S. J. (1994). Assessment of eating disorders: Interview or self-report questionnaire? International Journal of Eating Disorders, 16(4), 363–370. PubMed PMID 7866415.
Garner, D. M., Olmsted, M. P., Bohr, Y., & Garfinkel, P. E. (1982). The eating attitudes test: Psychometric features and clinical correlates. Psychological Medicine, 12(4), 871–878. https://doi.org/10.1017/S0033291700049163
Herman, B. K., Deal, L. S., DiBenedetti, D. B., et al. (2016). Development of the 7-Item Binge-Eating Disorder Screener (BEDS-7). Primary Care Companion for CNS Disorders, 18(2). https://doi.org/10.4088/PCC.15m01896
Morgan, J. F., Reid, F., & Lacey, J. H. (1999). The SCOFF questionnaire: Assessment of a new screening tool for eating disorders. BMJ, 319, 1467–1468. https://doi.org/10.1136/bmj.319.7223.1467
National Institute for Health and Care Excellence. (2017, updated). Eating disorders: Recognition and treatment. NICE guideline NG69. https://www.nice.org.uk/guidance/ng69/chapter/recommendations
National Institute of Mental Health. Eating disorders: What you need to know. https://www.nimh.nih.gov/health/publications/eating-disorders
Papini, N. M., Jung, M., Cook, A., et al. (2022). Psychometric properties of the 26-item Eating Attitudes Test (EAT-26): An application of Rasch analysis. Journal of Eating Disorders, 10, 62. https://doi.org/10.1186/s40337-022-00580-3
Park, S.-H., & Kim, S.-Y. (2026). Screening accuracy of the Eating Disorder Examination Questionnaire: A systematic review and meta-analysis. Eating Behaviors, 62, 102107. https://doi.org/10.1016/j.eatbeh.2026.102107
Society for Adolescent Health and Medicine. (2022). Medical management of restrictive eating disorders in adolescents and young adults. Journal of Adolescent Health, 71(5), 648–654. https://doi.org/10.1016/j.jadohealth.2022.08.006
US Preventive Services Task Force. (2022). Eating disorders in adolescents and adults: Screening. Recommendation statement. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-eating-disorders-adolescents-adults
US Preventive Services Task Force evidence review. (2022). Screening for eating disorders in adolescents and adults: Evidence summary. JAMA, 327(11), 1068–1082. https://www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/screening-eating-disorders-adolescents-adults